• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

21

CATEGORIES

  • 28
  • 24
  • 22
  • 15
  • 13
  • 9
  • 7
  • 7
  • 5
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

51
70
78
125

PUBLISHED

2
6
42
125

PRODUCT TYPE

50
47
26
2

Search "Disease and Therapy Review: Epilepsy" returned 125 results.

Epilepsy - Pipeline Review, H1 2015

Epilepsy - Pipeline Review, H1 2015 Summary This, ‘Epilepsy - Pipeline Review, H1 2015’, provides an overview of the Epilepsy’s therapeutic pipeline. This report provides comprehensive information...

January 2015
FROM

Epilepsy - Pipeline Review, H2 2014

Epilepsy - Pipeline Review, H2 2014 Summary This, ‘Epilepsy - Pipeline Review, H2 2014’, provides an overview of the Epilepsy’s therapeutic pipeline. This report provides comprehensive information...

August 2014
FROM

Epilepsy - Pipeline Review, H1 2014

Epilepsy - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Epilepsy - Pipeline Review, H1 2014’, provides an overview of the Epilepsy’s therapeutic pipeline. This report provides comprehensive...

February 2014
FROM

PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures....

December 2013
FROM
Cell Therapy - Technologies, Markets and Companies Cell Therapy - Technologies, Markets and Companies - Product Thumbnail Image

Cell Therapy - Technologies, Markets and Companies

This report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine. Hematopoietic stem cell transplantation is...

August 2015
FROM

CNS Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for CNS Therapeutics in US$ Million by the following Product Groups: Anti-Alzheimer's, Anti-Parkinson's, Anti-Epilepsy, Pain Management, Anti-Psychotics, Anti-Depressants,...

February 2015
FROM

PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis

PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis Summary Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven...

January 2013
FROM

Epilepsy - Pipeline Review, H2 2013

Epilepsy - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Epilepsy - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

August 2013
FROM

Disease & Therapy Review (DTR) Executive Market Summaries

Disease & Therapy Review is meant to be an accurate and efficient executive synopsis of the indications that IPD users look up most frequently Each report includes epidemiology from the IPD (Incidence...

May 2015

Epilepsy - Pipeline Review, H1 2013

Epilepsy – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Epilepsy - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

February 2013
FROM
Recent Developments in the CNS Drug Market Recent Developments in the CNS Drug Market - Product Thumbnail Image

Recent Developments in the CNS Drug Market

This report reviews the global market for CNS prescription drugs and recent developments within the marketplace, including collaborative agreements, recent clinical trial results and new product approvals...

October 2013
FROM

The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis

“The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis ” The report provides in-depth analysis of unmet...

December 2009
FROM

Neurotrek, Inc. - Product Pipeline Analysis, 2013 Update

Summary Neurotrek, Inc. (Neurotrek) is a biotechnology company. The company develops and offers U+, a targeted, non-invasive neuromodulation technology. Its U+ is a proprietary platform which uses...

January 2014
FROM

Epilepsy in Children and Adolescents

This book provides the contemporary, caring guidance you need to diagnose and manage seizures in a young patient. Beginning with an overview of the classification of seizure syndromes, the authors take...

November 2012

Neurotrek, Inc. - Product Pipeline Analysis

Summary Neurotrek, Inc. (Neurotrek) is a biotechnology company. It focuses on the development of U+, a targeted, non-invasive neuromodulation technology. U+ is a proprietary platform that uses ultrasound...

December 2012
FROM

Cyberonics, Inc. (CYBX) - Product Pipeline Analysis, 2014 Update

Summary Cyberonics, Inc. (Cyberonics) is a medical technology company. The company designs, develops and markets medical devices for the treatment of epilepsy and other psychiatric diseases. It develops...

October 2014
FROM

Cactus Semiconductor, Inc. - Product Pipeline Analysis, 2013 Update

Summary Cactus Semiconductor, Inc. (Cactus) is a semiconductor company. The company provides custom analog and mixed signal integrated circuits. It provides integrated circuit design services, circuit...

December 2013
FROM

Partial Seizure - Pipeline Review, H2 2013

Partial Seizure - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Partial Seizure - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

October 2013
FROM

Partial Seizure - Pipeline Review, H1 2014

Partial Seizure - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Partial Seizure - Pipeline Review, H1 2014’, provides an overview of the Partial Seizure’s therapeutic pipeline. This...

April 2014
FROM

NeuroSigma, Inc. - Product Pipeline Analysis

Summary NeuroSigma, Inc. (NeuroSigma) is a medical device company involved in the development of early stage technologies to transform medical practice. NeuroSigma concentrates on a number of neuromodulation...

December 2012
FROM
Loading Indicator

Our Clients

Glanbia Plc. Unilever N.V. Microsoft Corporation Duke University A.T. Kearney PepsiCo Inc. Boston Consulting Group